Cargando…

IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE

BACKGROUND: The world symposium on pulmonary hypertension (PH) has proposed that PH be defined as a mean pulmonary artery pressure (mPAP) > 20 mmHg as assessed by right heart catheterisation (RHC). Transthoracic echocardiography (TTE) is an established screening tool used for suspected PH. Intern...

Descripción completa

Detalles Bibliográficos
Autores principales: Slegg, Oliver Graham, Willis, James Alexander, Wilkinson, Fiona, Sparey, Joseph, Wild, Christopher Basil, Rossdale, Jennifer, Ross, Robert Mackenzie, Pauling, John D., Carson, Kevin, Kandan, Sri Raveen, Oxborough, David, Knight, Daniel, Peacock, Oliver James, Suntharalingam, Jay, Coghlan, John Gerard, Augustine, Daniel Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580132/
https://www.ncbi.nlm.nih.gov/pubmed/36258244
http://dx.doi.org/10.1186/s44156-022-00010-9
_version_ 1784812327328022528
author Slegg, Oliver Graham
Willis, James Alexander
Wilkinson, Fiona
Sparey, Joseph
Wild, Christopher Basil
Rossdale, Jennifer
Ross, Robert Mackenzie
Pauling, John D.
Carson, Kevin
Kandan, Sri Raveen
Oxborough, David
Knight, Daniel
Peacock, Oliver James
Suntharalingam, Jay
Coghlan, John Gerard
Augustine, Daniel Xavier
author_facet Slegg, Oliver Graham
Willis, James Alexander
Wilkinson, Fiona
Sparey, Joseph
Wild, Christopher Basil
Rossdale, Jennifer
Ross, Robert Mackenzie
Pauling, John D.
Carson, Kevin
Kandan, Sri Raveen
Oxborough, David
Knight, Daniel
Peacock, Oliver James
Suntharalingam, Jay
Coghlan, John Gerard
Augustine, Daniel Xavier
author_sort Slegg, Oliver Graham
collection PubMed
description BACKGROUND: The world symposium on pulmonary hypertension (PH) has proposed that PH be defined as a mean pulmonary artery pressure (mPAP) > 20 mmHg as assessed by right heart catheterisation (RHC). Transthoracic echocardiography (TTE) is an established screening tool used for suspected PH. International guidelines recommend a multi-parameter assessment of the TTE PH probability although effectiveness has not been established using real world data. STUDY AIMS: To determine accuracy of the European Society of Cardiology (ESC) and British Society of Echocardiography (BSE) TTE probability algorithm in detecting PH in patients attending a UK PH centre. To identify echocardiographic markers and revised algorithms to improve the detection of PH in those with low/intermediate BSE/ESC TTE PH probability. METHODS: TTE followed by RHC (within 4 months after) was undertaken in patients for suspected but previously unconfirmed PH. BSE/ESC PH TTE probabilities were calculated alongside additional markers of right ventricular (RV) longitudinal and radial function, and RV diastolic function. A refined IMPULSE algorithm was devised and evaluated in patients with low and/or intermediate ESC/BSE TTE PH probability. RESULTS: Of 310 patients assessed, 236 (76%) had RHC-confirmed PH (average mPAP 42.8 ± 11.7). Sensitivity and specificity for detecting PH using the BSE/ESC recommendations was 89% and 68%, respectively. 36% of those with low BSE/ESC TTE probability had RHC-confirmed PH and BSE/ESC PH probability parameters did not differ amongst those with and without PH in the low probability group. Conversely, RV free wall longitudinal strain (RVFWLS) was lower in patients with vs. without PH in low BSE/ESC probability group (− 20.6 ± 4.1% vs − 23.8 ± 3.9%) (P < 0.02). Incorporating RVFWLS and TTE features of RV radial and diastolic function (RVFAC and IVRT) within the IMPULSE algorithm reduced false negatives in patients with low BSE/ESC PH probability by 29%. The IMPULSE algorithm had excellent specificity and positive predictive value in those with low (93%/80%, respectively) or intermediate (82%/86%, respectively) PH probability. CONCLUSION: Existing TTE PH probability guidelines lack sensitivity to detect patients with milder haemodynamic forms of PH. Combining additional TTE makers assessing RV radial, longitudinal and diastolic function enhance identification of milder forms of PH, particularly in those who have a low BSE/ESC TTE PH probability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s44156-022-00010-9.
format Online
Article
Text
id pubmed-9580132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95801322022-10-20 IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE Slegg, Oliver Graham Willis, James Alexander Wilkinson, Fiona Sparey, Joseph Wild, Christopher Basil Rossdale, Jennifer Ross, Robert Mackenzie Pauling, John D. Carson, Kevin Kandan, Sri Raveen Oxborough, David Knight, Daniel Peacock, Oliver James Suntharalingam, Jay Coghlan, John Gerard Augustine, Daniel Xavier Echo Res Pract Research BACKGROUND: The world symposium on pulmonary hypertension (PH) has proposed that PH be defined as a mean pulmonary artery pressure (mPAP) > 20 mmHg as assessed by right heart catheterisation (RHC). Transthoracic echocardiography (TTE) is an established screening tool used for suspected PH. International guidelines recommend a multi-parameter assessment of the TTE PH probability although effectiveness has not been established using real world data. STUDY AIMS: To determine accuracy of the European Society of Cardiology (ESC) and British Society of Echocardiography (BSE) TTE probability algorithm in detecting PH in patients attending a UK PH centre. To identify echocardiographic markers and revised algorithms to improve the detection of PH in those with low/intermediate BSE/ESC TTE PH probability. METHODS: TTE followed by RHC (within 4 months after) was undertaken in patients for suspected but previously unconfirmed PH. BSE/ESC PH TTE probabilities were calculated alongside additional markers of right ventricular (RV) longitudinal and radial function, and RV diastolic function. A refined IMPULSE algorithm was devised and evaluated in patients with low and/or intermediate ESC/BSE TTE PH probability. RESULTS: Of 310 patients assessed, 236 (76%) had RHC-confirmed PH (average mPAP 42.8 ± 11.7). Sensitivity and specificity for detecting PH using the BSE/ESC recommendations was 89% and 68%, respectively. 36% of those with low BSE/ESC TTE probability had RHC-confirmed PH and BSE/ESC PH probability parameters did not differ amongst those with and without PH in the low probability group. Conversely, RV free wall longitudinal strain (RVFWLS) was lower in patients with vs. without PH in low BSE/ESC probability group (− 20.6 ± 4.1% vs − 23.8 ± 3.9%) (P < 0.02). Incorporating RVFWLS and TTE features of RV radial and diastolic function (RVFAC and IVRT) within the IMPULSE algorithm reduced false negatives in patients with low BSE/ESC PH probability by 29%. The IMPULSE algorithm had excellent specificity and positive predictive value in those with low (93%/80%, respectively) or intermediate (82%/86%, respectively) PH probability. CONCLUSION: Existing TTE PH probability guidelines lack sensitivity to detect patients with milder haemodynamic forms of PH. Combining additional TTE makers assessing RV radial, longitudinal and diastolic function enhance identification of milder forms of PH, particularly in those who have a low BSE/ESC TTE PH probability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s44156-022-00010-9. BioMed Central 2022-10-19 /pmc/articles/PMC9580132/ /pubmed/36258244 http://dx.doi.org/10.1186/s44156-022-00010-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Slegg, Oliver Graham
Willis, James Alexander
Wilkinson, Fiona
Sparey, Joseph
Wild, Christopher Basil
Rossdale, Jennifer
Ross, Robert Mackenzie
Pauling, John D.
Carson, Kevin
Kandan, Sri Raveen
Oxborough, David
Knight, Daniel
Peacock, Oliver James
Suntharalingam, Jay
Coghlan, John Gerard
Augustine, Daniel Xavier
IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE
title IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE
title_full IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE
title_fullStr IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE
title_full_unstemmed IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE
title_short IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE
title_sort improving pulmonary hypertension screening by echocardiography: impulse
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580132/
https://www.ncbi.nlm.nih.gov/pubmed/36258244
http://dx.doi.org/10.1186/s44156-022-00010-9
work_keys_str_mv AT sleggolivergraham improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT willisjamesalexander improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT wilkinsonfiona improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT spareyjoseph improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT wildchristopherbasil improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT rossdalejennifer improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT rossrobertmackenzie improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT paulingjohnd improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT carsonkevin improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT kandansriraveen improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT oxboroughdavid improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT knightdaniel improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT peacockoliverjames improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT suntharalingamjay improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT coghlanjohngerard improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse
AT augustinedanielxavier improvingpulmonaryhypertensionscreeningbyechocardiographyimpulse